A novel mitochondrial mutation, 1556C→T, in a Japanese patient with streptomycin-induced tinnitus
Objective Aminoglycoside antibiotics are associated with ototoxicity. The 1555A→G mutation in the 12S ribosomal RNA gene of mitochondrial DNA has been considered to be associated with susceptibility to aminoglycoside antibiotics. In this study we examined a 79-year-old Japanese patient with a 45-yea...
Gespeichert in:
Veröffentlicht in: | Acta oto-laryngologica 2004-03, Vol.124 (3), p.258-261 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Objective
Aminoglycoside antibiotics are associated with ototoxicity. The 1555A→G mutation in the 12S ribosomal RNA gene of mitochondrial DNA has been considered to be associated with susceptibility to aminoglycoside antibiotics. In this study we examined a 79-year-old Japanese patient with a 45-year history of streptomycin-induced tinnitus in an attempt to find a mitochondrial mutation.
Materials and Methods
DNA was extracted from the patient's leukocytes. Polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP) screening for the 1555A→G mutation was done in order to detect a mitochondrial mutation and then nucleotide sequencing analysis was performed to identify the mutation.
Results
PCR-RFLP screening detected the presence of a mitochondrial mutation in the patient. However, the nucleotide sequencing analysis showed that the mutation was not the 1555A→G mutation but a novel mutation, 1556C→T. The mutation was not found in 112 unrelated Japanese control subjects, suggesting that the mutation was specific to our patient.
Conclusions
The 1556C→T mutation may be a genetic risk factor for aminoglycoside-induced hearing impairment. Our result also suggests that patients with the 1556C→T mutation exist among those expected to have the 1555A→G mutation as a result of PCR-RFLP analysis. |
---|---|
ISSN: | 0001-6489 1651-2251 |
DOI: | 10.1080/00016480310015740 |